Scaffolding for Three-Dimensional Embryonic Vasculogenesis

  • Thomas P. Kraehenbuehl
  • Sezin Aday
  • Lino S. Ferreira
Chapter
Part of the Biological and Medical Physics, Biomedical Engineering book series (BIOMEDICAL)

Abstract

Biomaterial scaffolds have great potential to support efficient vascular differentiation of embryonic stem cells. Vascular cell fate-specific biochemical and biophysical cues have been identified and incorporated into three-dimensional (3D) biomaterials to efficiently direct embryonic vasculogenesis. The resulting vascular-like tissue can be used for regenerative medicine applications, further elucidation of biophysical and biochemical cues governing vasculogenesis, and drug discovery. In this chapter, we give an overview on the following: (1) developmental cues for directed differentiation of human embryonic stem cells (hESCs) into vascular cells, (2) 3D vascular differentiation in embryoid bodies (EBs), (3) preparation of 3D scaffolds for the vascular differentiation of hESCs, and (4) the most significant studies combining scaffolding and hESCs for development of vascular-like tissue.

Keywords

Polysaccharide Immobilization Polystyrene Thiol Integrin 

Notes

Acknowledgments

This work was supported in part by NIH (grant HL060435). TPK was supported by the Swiss National Science Foundation (grant number PBELP3-127902). SA was supported by the FCT (grant number SFRH/BD/42871/2008). LF was supported by a Marie Curie-Reintegration Grant, MIT-Portugal program, Crioestaminal, Associação Viver a Ciência, and FCT (PTDC/SA-BEB/098468/2008; PTDC/CTM/099659/2008).

References

  1. 1.
    Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–1147.CrossRefADSGoogle Scholar
  2. 2.
    Ferguson JE, 3rd, Kelley RW, Patterson C. Mechanisms of endothelial differentiation in embryonic vasculogenesis. Arterioscler Thromb Vasc Biol. 2005;25:2246–2254.CrossRefGoogle Scholar
  3. 3.
    Yang L, Soonpaa MH, Adler ED, et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature. 2008;453:524–528.CrossRefADSGoogle Scholar
  4. 4.
    Li Z, Wilson KD, Smith B, et al. Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction. PLoS One. 2009;4:e8443.CrossRefADSGoogle Scholar
  5. 5.
    Cho SW, Moon SH, Lee SH, et al. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation. 2007;116:2409–2419.CrossRefGoogle Scholar
  6. 6.
    Schmidt A, Brixius K, Bloch W. Endothelial precursor cell migration during vasculogenesis. Circ Res. 2007;101:125–136.CrossRefGoogle Scholar
  7. 7.
    Astrof S, Hynes RO. Fibronectins in vascular morphogenesis. Angiogenesis. 2009;12:165–175.CrossRefGoogle Scholar
  8. 8.
    Hynes RO. Cell-matrix adhesion in vascular development. J Thromb Haemost. 2007;5 Suppl 1:32–40.CrossRefGoogle Scholar
  9. 9.
    Levenberg S, Huang NF, Lavik E, et al. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci U S A. 2003;100:12741–12746.CrossRefADSGoogle Scholar
  10. 10.
    Ferreira LS, Gerecht S, Fuller J, et al. Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials. 2007;28:2706–2717.CrossRefGoogle Scholar
  11. 11.
    Kraehenbuehl TP, Zammaretti P, Van der Vlies AJ, et al. Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: systematic modulation of a synthetic cell-responsive PEG-hydrogel. Biomaterials. 2008;29:2757–2766.CrossRefGoogle Scholar
  12. 12.
    Ribatti D, Nico B, Crivellato E. Morphological and molecular aspects of physiological vascular morphogenesis. Angiogenesis. 2009;12:101–111.CrossRefGoogle Scholar
  13. 13.
    Kennedy M, D’Souza SL, Lynch-Kattman M, et al. Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood. 2007;109:2679–2687.Google Scholar
  14. 14.
    Jakobsson L, Kreuger J, Claesson-Welsh L. Building blood vessels – stem cell models in vascular biology. J Cell Biol. 2007;177:751–755.CrossRefGoogle Scholar
  15. 15.
    Levenberg S, Golub JS, Amit M, et al. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A. 2002;99:4391–4396.CrossRefADSGoogle Scholar
  16. 16.
    Wang L, Li L, Shojaei F, et al. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity. 2004;21:31–41.CrossRefGoogle Scholar
  17. 17.
    Gerecht-Nir S, Ziskind A, Cohen S, et al. Human embryonic stem cells as an in vitro model for human vascular development and the induction of vascular differentiation. Lab Invest. 2003;83:1811–1820.CrossRefGoogle Scholar
  18. 18.
    Levenberg S, Zoldan J, Basevitch Y, et al. Endothelial potential of human embryonic stem cells. Blood. 2007;110:806–814.CrossRefGoogle Scholar
  19. 19.
    Cerdan C, Rouleau A, Bhatia M. VEGF-A165 augments erythropoietic development from human embryonic stem cells. Blood. 2004;103:2504–2512.CrossRefGoogle Scholar
  20. 20.
    Ferreira L, Squier T, Park H, et al. Human embryoid bodies containing nano- and microparticulate delivery vehicles. Adv Mater. 2008;20:2285–2291.CrossRefGoogle Scholar
  21. 21.
    Ferreira LS, Gerecht S, Shieh HF, et al. Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circ Res. 2007;101:286–294.CrossRefGoogle Scholar
  22. 22.
    Zhang P, Li J, Tan Z, et al. Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells. Blood. 2008;111:1933–1941.CrossRefGoogle Scholar
  23. 23.
    Francis SE, Goh KL, Hodivala-Dilke K, et al. Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler Thromb Vasc Biol. 2002;22:927–933.CrossRefGoogle Scholar
  24. 24.
    George EL, Baldwin HS, Hynes RO. Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells. Blood. 1997;90:3073–3081.Google Scholar
  25. 25.
    Levenberg S. Engineering blood vessels from stem cells: recent advances and applications. Curr Opin Biotechnol. 2005;16:516–523.CrossRefGoogle Scholar
  26. 26.
    Bai H, Wang ZZ. Directing human embryonic stem cells to generate vascular progenitor cells. Gene Ther. 2008;15:89–95.CrossRefGoogle Scholar
  27. 27.
    Gerecht-Nir S, Osenberg S, Nevo O, et al. Vascular development in early human embryos and in teratomas derived from human embryonic stem cells. Biol Reprod. 2004;71:2029–2036.CrossRefGoogle Scholar
  28. 28.
    Gerecht-Nir S, Dazard JE, Golan-Mashiach M, et al. Vascular gene expression and phenotypic correlation during differentiation of human embryonic stem cells. Dev Dyn. 2005;232:487–497.CrossRefGoogle Scholar
  29. 29.
    Ng ES, Davis RP, Hatzistavrou T, et al. Directed differentiation of human embryonic stem cells as spin embryoid bodies and a description of the hematopoietic blast colony forming assay. Curr Protoc Stem Cell Biol. 2008;Chapter 1:Unit 1D 3.Google Scholar
  30. 30.
    Cerdan C, Hong SH, Bhatia M. Formation and hematopoietic differentiation of human embryoid bodies by suspension and hanging drop cultures. Curr Protoc Stem Cell Biol. 2007; Chapter 1:Unit 1D 2.
  31. 31.
    Khademhosseini A, Ferreira L, Blumling J, 3rd, et al. Co-culture of human embryonic stem cells with murine embryonic fibroblasts on microwell-patterned substrates. Biomaterials. 2006;27:5968–5977.CrossRefGoogle Scholar
  32. 32.
    Ungrin MD, Joshi C, Nica A, et al. Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates. PLoS One. 2008;3:e1565.CrossRefADSGoogle Scholar
  33. 33.
    Ng ES, Davis RP, Azzola L, et al. Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation. Blood. 2005;106:1601–1603.CrossRefGoogle Scholar
  34. 34.
    Bauwens CL, Peerani R, Niebruegge S, et al. Control of human embryonic stem cell colony and aggregate size heterogeneity influences differentiation trajectories. Stem Cells. 2008;26:2300–2310.CrossRefGoogle Scholar
  35. 35.
    Hwang YS, Chung BG, Ortmann D, et al. Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11. Proc Natl Acad Sci U S A. 2009;106:16978–16983.CrossRefADSGoogle Scholar
  36. 36.
    Gerecht-Nir S, Cohen S, Itskovitz-Eldor J. Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation. Biotechnol Bioeng. 2004;86:493–502.CrossRefGoogle Scholar
  37. 37.
    Dang SM, Gerecht-Nir S, Chen J, et al. Controlled, scalable embryonic stem cell differentiation culture. Stem Cells. 2004;22:275–282.CrossRefGoogle Scholar
  38. 38.
    Fok EY, Zandstra PW. Shear-controlled single-step mouse embryonic stem cell expansion and embryoid body-based differentiation. Stem Cells. 2005;23:1333–1342.CrossRefGoogle Scholar
  39. 39.
    Schroeder M, Niebruegge S, Werner A, et al. Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control. Biotechnol Bioeng. 2005;92:920–933.CrossRefGoogle Scholar
  40. 40.
    Zandstra PW, Bauwens C, Yin T, et al. Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng. 2003;9:767–778.CrossRefGoogle Scholar
  41. 41.
    Sachlos E, Auguste DT. Embryoid body morphology influences diffusive transport of inductive biochemicals: a strategy for stem cell differentiation. Biomaterials. 2008;29:4471–4480.CrossRefGoogle Scholar
  42. 42.
    Nguyen TH, Eichmann A, Le Noble F, et al. Dynamics of vascular branching morphogenesis: the effect of blood and tissue flow. Phys Rev E Stat Nonlin Soft Matter Phys. 2006;73:061907.CrossRefGoogle Scholar
  43. 43.
    Philp D, Chen SS, Fitzgerald W, et al. Complex extracellular matrices promote tissue-specific stem cell differentiation. Stem Cells. 2005;23:288–296.CrossRefGoogle Scholar
  44. 44.
    Metallo CM, Vodyanik MA, de Pablo JJ, et al. The response of human embryonic stem cell-derived endothelial cells to shear stress. Biotechnol Bioeng. 2008;100:830–837.CrossRefGoogle Scholar
  45. 45.
    Ofek G, Willard VP, Koay EJ, et al. Mechanical characterization of differentiated human embryonic stem cells. J Biomech Eng. 2009;131:061011.CrossRefGoogle Scholar
  46. 46.
    Discher DE, Janmey P, Wang YL. Tissue cells feel and respond to the stiffness of their substrate. Science. 2005;310:1139–1143.CrossRefADSGoogle Scholar
  47. 47.
    Silva GA, Czeisler C, Niece KL, et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science. 2004;303:1352–1355.CrossRefADSGoogle Scholar
  48. 48.
    Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol. 2005;23:47–55.CrossRefGoogle Scholar
  49. 49.
    Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and ­applications. Biomaterials. 2003;24:4337–4351.CrossRefGoogle Scholar
  50. 50.
    Burdick JA, Ward M, Liang E, et al. Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels. Biomaterials. 2006;27:452–459.CrossRefGoogle Scholar
  51. 51.
    Kraehenbuehl TP, Ferreira LS, Zammaretti P, et al. Cell-responsive hydrogel for encapsulation of vascular cells. Biomaterials. 2009;30:4318–4324.CrossRefGoogle Scholar
  52. 52.
    Griffith LG. Polymeric biomaterials. Acta Mater. 2000;48:263–277.CrossRefGoogle Scholar
  53. 53.
    Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials. 2000;21:2475–2490.CrossRefGoogle Scholar
  54. 54.
    Hirano Y, Mooney DJ. Peptide and protein presenting materials for tissue engineering. Adv Mater. 2004;16:17–25.CrossRefGoogle Scholar
  55. 55.
    Hwang NS, Varghese S, Elisseeff J. Derivation of chondrogenically-committed cells from human embryonic cells for cartilage tissue regeneration. PLoS One. 2008;3:e2498.CrossRefADSGoogle Scholar
  56. 56.
    Carlberg B, Axell MZ, Nannmark U, et al. Electrospun polyurethane scaffolds for proliferation and neuronal differentiation of human embryonic stem cells. Biomed Mater. 2009;4:45004.CrossRefGoogle Scholar
  57. 57.
    Gauthaman K, Venugopal JR, Yee FC, et al. Nanofibrous substrates support colony formation and maintain stemness of human embryonic stem cells. J Cell Mol Med. 2009;13:3475–3484.CrossRefGoogle Scholar
  58. 58.
    Gerecht S, Bettinger CJ, Zhang Z, et al. The effect of actin disrupting agents on contact guidance of human embryonic stem cells. Biomaterials. 2007;28:4068–4077.CrossRefGoogle Scholar
  59. 59.
    Levenberg S, Burdick JA, Kraehenbuehl T, et al. Neurotrophin-induced differentiation of human embryonic stem cells on three-dimensional polymeric scaffolds. Tissue Eng. 2005;11:506–512.CrossRefGoogle Scholar
  60. 60.
    Gerecht-Nir S, Cohen S, Ziskind A, et al. Three-dimensional porous alginate scaffolds provide a conducive environment for generation of well-vascularized embryoid bodies from human embryonic stem cells. Biotechnol Bioeng. 2004;88:313–320.CrossRefGoogle Scholar
  61. 61.
    Leor J, Gerecht S, Cohen S, et al. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart. 2007;93:1278–1284.CrossRefGoogle Scholar
  62. 62.
    Zmora S, Glicklis R, Cohen S. Tailoring the pore architecture in 3-D alginate scaffolds by controlling the freezing regime during fabrication. Biomaterials. 2002;23:4087–4094.CrossRefGoogle Scholar
  63. 63.
    Lindenhayn K, Perka C, Spitzer R, et al. Retention of hyaluronic acid in alginate beads: aspects for in vitro cartilage engineering. J Biomed Mater Res. 1999;44:149–155.CrossRefGoogle Scholar
  64. 64.
    Smetana K. Cell biology of hydrogels. Biomaterials. 1993;14:1046–1050.CrossRefGoogle Scholar
  65. 65.
    Ferreira L, Gil MH, Cabrita AM, et al. Biocatalytic synthesis of highly ordered degradable dextran-based hydrogels. Biomaterials. 2005;26:4707–4716.CrossRefGoogle Scholar
  66. 66.
    Ferreira L, Rafael A, Lamghari M, et al. Biocompatibility of chemoenzymatically derived dextran-acrylate hydrogels. J Biomed Mater Res A. 2004;68:584–596.CrossRefGoogle Scholar
  67. 67.
    Mehvar R. Dextrans for targeted and sustained delivery of therapeutic and imaging agents. J Control Release. 2000;69:1–25.CrossRefGoogle Scholar
  68. 68.
    Ferreira L, Figueiredo MM, Gil MH, et al. Structural analysis of dextran-based hydrogels obtained chemoenzymatically. J Biomed Mater Res B Appl Biomater. 2006;77B:55–64.CrossRefGoogle Scholar
  69. 69.
    Brusselmans K, Bono F, Collen D, et al. A novel role for vascular endothelial growth factor as an autocrine survival factor for embryonic stem cells during hypoxia. J Biol Chem. 2005;280:3493–3499.CrossRefGoogle Scholar
  70. 70.
    Gerecht S, Burdick JA, Ferreira LS, et al. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A. 2007;104:11298–11303.CrossRefADSGoogle Scholar
  71. 71.
    Choudhary M, Zhang X, Stojkovic P, et al. Putative role of hyaluronan and its related genes, HAS2 and RHAMM, in human early preimplantation embryogenesis and embryonic stem cell characterization. Stem Cells. 2007;25:3045–3057.CrossRefGoogle Scholar
  72. 72.
    Burdick JA, Chung C, Jia X, et al. Controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks. Biomacromolecules. 2005;6:386–391.CrossRefGoogle Scholar
  73. 73.
    Vercruysse KP, Marecak DM, Marecek JF, et al. Synthesis and in vitro degradation of new polyvalent hydrazide cross-linked hydrogels of hyaluronic acid. Bioconjug Chem. 1997;8:686–694.CrossRefGoogle Scholar
  74. 74.
    Sakai S, Kawabata K, Ono T, et al. Preparation of mammalian cell-enclosing subsievesized capsules (<100 microm) in a coflowing stream. Biotechnol Bioeng. 2004;86:168–173.CrossRefGoogle Scholar
  75. 75.
    Mu Y, Lyddiatt A, Pacek AW. Manufacture by water/oil emulsification of porous agarose beads: effect of processing conditions on mean particle size, size distribution and mechanical properties. Chem Eng Process. 2005;44:1157–1166.CrossRefGoogle Scholar
  76. 76.
    Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem Rev. 2001;101:1869–1879.CrossRefGoogle Scholar
  77. 77.
    Li WJ, Laurencin CT, Caterson EJ, et al. Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res. 2002;60:613–621.CrossRefGoogle Scholar
  78. 78.
    Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials. 2005;26:5474–5491.CrossRefGoogle Scholar
  79. 79.
    Gerecht S, Townsend SA, Pressler H, et al. A porous photocurable elastomer for cell encapsulation and culture. Biomaterials. 2007;28:4826–4835.CrossRefGoogle Scholar
  80. 80.
    Khademhosseini A, Langer R, Borenstein J, et al. Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci U S A. 2006;103:2480–2487.CrossRefADSGoogle Scholar
  81. 81.
    Ferreira L, Karp JM, Nobre L, et al. New opportunities: the use of nanotechnologies to manipulate and track stem cells. Cell Stem Cell. 2008;3:136–146.CrossRefGoogle Scholar
  82. 82.
    Anderson DG, Levenberg S, Langer R. Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells. Nat Biotechnol. 2004;22:863–866.CrossRefGoogle Scholar
  83. 83.
    Derda R, Musah S, Orner BP, et al. High-throughput discovery of synthetic surfaces that support proliferation of pluripotent cells. J Am Chem Soc. 2010;132:1289–1295.CrossRefGoogle Scholar
  84. 84.
    Kraehenbuehl TP, Ferreira LS, Hayward AM, et al. Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials. 2010 (in press).Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Thomas P. Kraehenbuehl
  • Sezin Aday
  • Lino S. Ferreira
    • 1
    • 2
  1. 1.Biocant, Centro de Inovação em BiotecnologiaCantanhedePortugal
  2. 2.Center of Neurosciences and Cell BiologyUniversity of CoimbraCoimbraPortugal

Personalised recommendations